
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [ADAP] Adaptimmune Therapeutics plc
Data updated 2025-May-28 (Wednesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-May-28 Wednesday
Open | $0.28 | High | $0.29 +2.58% |
---|---|---|---|
Close | $0.27 | Low | $0.27 -3.40% |
Volume | 256 Thousand 0.54x | Volatility | 6.18% |
Change |
$-0.01
-3.28%
|
Streak | ↓ 1 days -3.28% |
20d SMA | $0.28 -4.1% | 50d SMA | $0.27 -0.3% | 100d SMA | $0.42 -35.2% | 200d SMA | $0.64 -57.6% |
RSI | 46 | MACD | 0.0 | ADX | 14.5 | Stochastic Oscillator | 38.8 38.9 |
CCI | -52.3 | ATR | 0.03 | OBV | 107 Million | Chaikin A/D | -146 Million |
Market Cap | 341 M | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 4.6 | Price/Book (mrq) | 8.62 | EV/Revenue (ttm) | 3.63 | EV/EBITDA (ttm) | -1.71 |
% Held by Insiders | 0.21% | % Held by Institutions | 70.02% | Shares Short | 3.11 M | Shares Short (prior month) | 2.93 M |
Short Ratio | 1.55 | Short % of Outstanding | 1.26% | Short % of Float | 0.47% | Shares Short Change (mom) | +6.1% |
Revenue/Share (ttm) | $0.30 | Profit Margin (ttm) | -188.90% | Operating Margin (ttm) | EBITDA (ttm) | -128 M | |
Diluted EPS (ttm) | $-0.54 | Current Ratio (mrq) | 2.85 | Return on Assets (ttm) | -28.22% | Return on Equity (ttm) | -187.61% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | -97.90% | Operating Cash Flow (ttm) | -141 M | Free Cash Flow (ttm) | -73.8 M | |
Choose view type
Daily Performance for Adaptimmune Therapeutics plc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Adaptimmune Therapeutics plc up to close of 2025-May-28 at $0.27
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
-5.64%
|
-9.5%
|
+4.3%
|
15.4%
|
-1.8%
|
-2.0%
|
0.54x
|
02 Trailing 10-days
|
|
+8.44%
|
-10.2%
|
+8.5%
|
20.0%
|
-2.3%
|
-2.5%
|
0.43x
|
03 Trailing 20-days
|
|
+3.04%
|
-16.9%
|
+10.2%
|
32.0%
|
-4.1%
|
-2.7%
|
0.79x
|
04 Trailing 30-days
|
|
+15.90%
|
-16.9%
|
+19.0%
|
43.5%
|
-1.0%
|
-4.5%
|
0.66x
|
05 Trailing 50-days
|
|
-40.64%
|
-42.3%
|
+39.0%
|
135.0%
|
-0.3%
|
-13.1%
|
1.30x
|
06 Trailing 100-days
|
|
-49.68%
|
-60.4%
|
+39.0%
|
245.0%
|
-35.2%
|
-33.7%
|
0.95x
|
07 Trailing 200-days
|
|
-72.53%
|
-79.6%
|
+39.0%
|
565.0%
|
-57.6%
|
-52.9%
|
0.93x
|
08 Month-to-date
|
|
-2.02%
|
-16.9%
|
+10.2%
|
32.0%
|
|
|
|
09 Quarter-to-date
|
|
+37.61%
|
-17.9%
|
+39.0%
|
65.0%
|
|
|
|
10 Year-to-date
|
|
-49.68%
|
-60.4%
|
+39.0%
|
245.0%
|
|
|
|
11 Trailing 52-weeks
|
|
-73.93%
|
-81.7%
|
+39.0%
|
640.0%
|
|
|
|
3-month Performance Benchmarks for Adaptimmune Therapeutics plc:
Related to Adaptimmune Therapeutics plc
Information for Adaptimmune Therapeutics plc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-28 on Google
SEC Reports : Quarterly reports around 2025-May-28 on SEC Edgar
Compare Adaptimmune Therapeutics plc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Adaptimmune Therapeutics plc
Industry : Biotechnology industry performance which includes Adaptimmune Therapeutics plc